IBM Up 10 Days in a Row: What’s Driving the Winning Streak?

IBM shares have more than doubled since the start of 2024, fueled by advancements in AI and quantum computing, including plans for a large-scale quantum supercomputer by 2029. Q1 2025 earnings beat expectations with an EPS of $1.60 and revenue of $14.54 billion, alongside a 9% YOY increase in software sales driven by AI. Despite analyst upgrades and reaffirmed guidance projecting 5% revenue growth and $13.5 billion in free cash flow for the year, technical indicators suggest the stock may be overextended in the short term, potentially signaling a pullback.

Analysis

International Business Machines Corp. (IBM) has demonstrated a remarkable market resurgence, with its shares more than doubling since the start of 2024, including a 28% year-to-date advance and a recent 10-day winning streak. This rally is primarily fueled by strategic advancements in artificial intelligence and a detailed quantum computing roadmap. IBM plans to build the world's first large-scale "fault-tolerant" quantum supercomputer, the IBM Quantum Starling, by 2029, projected to possess 20,000 times the operational power of current systems, with clear developmental milestones including the Bluejay processor in 2033 targeting over one billion quantum operations. In the AI sector, IBM is carving a niche with "agentic AI" for enterprise applications, exemplified by its Granite AI model on the Watsonx platform, which contributed to software sales exceeding $6.3 billion in Q1 2025, a 9% year-over-year increase supported by 80% recurring revenue from products like Red Hat. The company's Q1 2025 earnings further bolstered investor confidence, reporting an EPS of $1.60 (beating $1.42 consensus) and revenue of $14.54 billion (above $14.41 billion expected), alongside a record $2 billion in free cash flow and a 240 basis point improvement in Q1 EBITDA margin. CEO Arvind Krishna reaffirmed full-year guidance of 5% revenue growth and $13.5 billion in free cash flow, with Red Hat's growth expected to accelerate to mid-teens and Q2 revenue projections slightly increased. This positive outlook is echoed by recent analyst upgrades, with an average price target of $291.67 from Wedbush, Royal Bank of Canada, and Bank of America, suggesting over 7% upside from current levels. However, technical indicators, specifically a daily Relative Strength Index (RSI) at 74, suggest the stock is in overbought territory, potentially signaling an imminent short-term pullback, as similar RSI levels have historically preceded temporary tops.

Key Decisions for Investors

• Investors should recognize IBM's compelling long-term growth narrative driven by its definitive quantum computing roadmap and expanding enterprise AI segment, which are supported by strong Q1 2025 financial results and positive full-year guidance.
• Caution is warranted in the short term due to technical indicators suggesting the stock is overextended, implying that waiting for a potential pullback or a consolidation phase might offer a more favorable entry point for new positions or additions.
• Monitoring the execution of IBM's quantum computing milestones, particularly the progress towards the Starling and Bluejay processors, and sustained growth in its AI-driven software and Red Hat revenues will be crucial for assessing the long-term investment thesis.